GlassScriptPhysician profile
Stephen J Plumb
NPI 1750458535
$1,396.29
in general payments reported to CMS, 2019-2025
20 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.56 · 2020: $271 · 2021: $208 · 2022: $236 · 2023: $81.81 · 2024: $342 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $301.93 | 2020-2025 | |
| Genzyme Corporation | $220.03 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $145.16 | 2020-2025 | Dupixent |
| Amgen INC. | $120.63 | 2020-2021 | |
| Organogenesis INC. | $107.95 | 2022-2025 | Cygnus Dual |
| Janssen Biotech, INC. | $100.18 | 2021-2024 | Tremfya, Simponi, Stelara |
| Ucb, INC. | $87.82 | 2019-2024 | Bimzelx |
| Genentech USA, INC. | $39.51 | 2022-2024 | Xolair |
| E.R. Squibb & Sons, L.L.C. | $39.26 | 2025 | Sotyktu |
| Lilly USA, LLC | $33.04 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.40 | 2024 | Spevigo |
| Kyowa Kirin, INC. | $23.36 | 2025 | |
| Celgene Corporation | $22.92 | 2019 | |
| Convatec INC. | $22.03 | 2024 | |
| Pfizer INC. | $21.55 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $21.42 | 2022 | |
| Bioventus LLC | $17.55 | 2022 | |
| Fresenius Kabi USA, LLC | $17.50 | 2024 | Idacio |
| Sun Pharmaceutical Industries INC. | $15.27 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.78 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Plumb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.